TrialJAMA2024

Ivonescimab Plus Chemotherapy in Non-Small Cell Lung Cancer With EGFR Variant: A Randomized Clinical Trial.

HARMONi-A Study Investigators et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.